In addition, we determined that the signature built from the perspective of the TIME has good performance in assessing the tumour mutation burden, immune cell infiltration, especially CD8 T cells, the expression levels of five immune checkpoint genes, and the response to immunotherapy. Here, CD8A is linked to neoplasm.